These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12871409)

  • 1. A study on associations between antiprothrombin antibodies, antiplasminogen antibodies and thrombosis.
    Simmelink MJ; De Groot PG; Derksen RH
    J Thromb Haemost; 2003 Apr; 1(4):735-9. PubMed ID: 12871409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study.
    Bizzaro N; Ghirardello A; Zampieri S; Iaccarino L; Tozzoli R; Ruffatti A; Villalta D; Tonutti E; Doria A
    J Thromb Haemost; 2007 Jun; 5(6):1158-64. PubMed ID: 17388963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Koike T; Hughes GR; Khamashta MA
    Thromb Haemost; 2005 Feb; 93(2):289-97. PubMed ID: 15711745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG antibodies to plasminogen and their relationship to IgG anti-beta(2)-glycoprotein 1 antibodies and thrombosis.
    Bu C; Li Z; Zhang C; Gao L; Cai G
    Clin Rheumatol; 2008 Feb; 27(2):171-8. PubMed ID: 17646899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
    Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
    Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of plasminogen activator inhibitor type 1, factor VIII, prothrombin activation fragment 1+2, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients.
    Molino D; De Santo NG; Marotta R; Anastasio P; Mosavat M; De Lucia D
    Semin Nephrol; 2004 Sep; 24(5):495-501. PubMed ID: 15490419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
    Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T
    Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J; Swadzba J; Motyl A; Iwaniec T
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
    Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
    Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
    Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
    Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupus anticoagulants and the risk of a first episode of deep venous thrombosis.
    de Groot PG; Lutters B; Derksen RH; Lisman T; Meijers JC; Rosendaal FR
    J Thromb Haemost; 2005 Sep; 3(9):1993-7. PubMed ID: 16102105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Khamashta MA; Amengual O; Hughes GR
    J Rheumatol; 1998 Jun; 25(6):1104-8. PubMed ID: 9632071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.
    Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y
    Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus.
    Bertolaccini ML; Mepani K; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2007 Apr; 66(4):533-6. PubMed ID: 17020907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays.
    Tsutsumi A; Hayashi T; Chino Y; Mamura M; Goto D; Matsumoto I; Ito S; Sumida T
    Mod Rheumatol; 2006; 16(3):158-64. PubMed ID: 16767554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interest of IgG and IgM antiprothrombin autoantibodies in the exploration of antiphospholipid syndrome: a 5-year retrospective study.
    Bertin D; Beziane A; Resseguier N; Pelissier M; Morange PE; Mege JL; Bardin N
    Rheumatology (Oxford); 2020 Jul; 59(7):1539-1544. PubMed ID: 31630203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.